Company CVAbout Sakar Healthcare Ltd 
Sakar Healthcare Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Sakar Healthcare Limited was incorporated as a Private Limited Company under the name "Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to "Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.
Company Coordinates
Company Details
10/13 Nr MN Desai Petrol Pump, Sarkhej Bavla Highway Changodar Gujarat : 382213
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 21.75 Cr
Number of Shares
2.17 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
28-Dec-2023
2.17
21.75
400000
10
Preferential basis
01-Sep-2023
2.13
21.35
2309910
10
Preferential basis
24-Feb-2023
1.9
19.04
422000
10
Preferential basis
08-Jul-2022
1.86
18.62
1500000
10
Preferential basis
17-Apr-2021
1.71
17.12
1500000
10
Preferential basis
27-Feb-2021
1.56
15.62
657000
10
Preferential basis
14-Oct-2016
1.1
10.96
2961000
10
Public Issues
14-Oct-2016
1.1
10.96
2961000
10
Public Issues
30-Mar-2011
8
8.00
600000
10
Allotment of Equity To Others
03-Oct-2009
74
7.40
400000
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 4 FIIs (13.31%)
Promoter with highest holding
Sanjay S Shah (44.98%)
Highest Public shareholder
Tata Capital Healthcare Fund Ii (10.38%)
Individual Investors Holdings
16.01%
Board of Directors
Management
Designation
Remuneration
Sanjay S Shah.
Chairman & Managing Director
48.0 lacs
Aarsh S Shah
Joint Managing Director
36.0 lacs
Ritaben S Shah
Whole-time Director
12.0 lacs
Shailesh B Patel
Independent Non Exe. Director
0
Prashant C Srivastav
Independent Non Exe. Director
0
Hemendrakumar C Shah
Independent Non Exe. Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Material Consumed
95.4673
0%
Cost of Material Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Contract Sales
8.69
12.73%
Contract Sales
Contract Sales
Stock DNARevenue and Profits:
Net Sales:
58 Cr
(Quarterly Results - Sep 2025)
Net Profit:
5 Cr
Pharmaceuticals & Biotechnology
INR Cr (Micro Cap)
43.00
NA
0.00%
0.00
0.00%
0.00
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
